 | • レポートコード：MRC2012B1582 • 出版社/出版日：GlobalInfoResearch / 2020年12月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、泌尿生殖器治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。泌尿生殖器治療の種類別市場規模（OTC、Rx薬）、用途別市場規模（病院、ドラッグストア、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Daiichi Sankyo Company、Sanofi、Astellas Pharma、Pfizer、Otsuka Pharmaceutical、Bayer、GSK、Allergan、 ・地域別グローバル市場分析 2015年-2020年 ・泌尿生殖器治療の北米市場（アメリカ、カナダ、メキシコ） ・泌尿生殖器治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・泌尿生殖器治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・泌尿生殖器治療の南米市場（ブラジル、アルゼンチン） ・泌尿生殖器治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：OTC、Rx薬 ・用途別分析：病院、ドラッグストア、その他 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Treatment for Genito-Urinary market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Treatment for Genito-Urinary market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Treatment for Genito-Urinary market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Treatment for Genito-Urinary market has been segmented into:
OTC
Rx Drugs
By Application, Treatment for Genito-Urinary has been segmented into:
Hospital
Drugs Store
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Treatment for Genito-Urinary market presented in the report. This section sheds light on the sales growth of different regional and country-level Treatment for Genito-Urinary markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Treatment for Genito-Urinary market.
The report offers in-depth assessment of the growth and other aspects of the Treatment for Genito-Urinary market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Treatment for Genito-Urinary Market Share Analysis
Treatment for Genito-Urinary competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Treatment for Genito-Urinary sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Treatment for Genito-Urinary sales, revenue and market share for each player covered in this report.
The major players covered in Treatment for Genito-Urinary are:
Daiichi Sankyo Company
Sanofi
Astellas Pharma
Pfizer
Otsuka Pharmaceutical
Bayer
GSK
Allergan
Table of Contents
1 Treatment for Genito-Urinary Market Overview
1.1 Product Overview and Scope of Treatment for Genito-Urinary
1.2 Classification of Treatment for Genito-Urinary by Type
1.2.1 Global Treatment for Genito-Urinary Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Treatment for Genito-Urinary Revenue Market Share by Type in 2019
1.2.3 OTC
1.2.4 Rx Drugs
1.3 Global Treatment for Genito-Urinary Market by Application
1.3.1 Overview: Global Treatment for Genito-Urinary Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Treatment for Genito-Urinary Market by Regions
1.4.1 Global Treatment for Genito-Urinary Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Treatment for Genito-Urinary (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Treatment for Genito-Urinary Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Treatment for Genito-Urinary Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Treatment for Genito-Urinary Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Treatment for Genito-Urinary Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Treatment for Genito-Urinary Status and Prospect (2015-2025)
2 Company Profiles
2.1 Daiichi Sankyo Company
2.1.1 Daiichi Sankyo Company Details
2.1.2 Daiichi Sankyo Company Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Daiichi Sankyo Company SWOT Analysis
2.1.4 Daiichi Sankyo Company Product and Services
2.1.5 Daiichi Sankyo Company Treatment for Genito-Urinary Revenue, Gross Margin and Market Share (2018-2019)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Sanofi SWOT Analysis
2.2.4 Sanofi Product and Services
2.2.5 Sanofi Treatment for Genito-Urinary Revenue, Gross Margin and Market Share (2018-2019)
2.3 Astellas Pharma
2.3.1 Astellas Pharma Details
2.3.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Astellas Pharma SWOT Analysis
2.3.4 Astellas Pharma Product and Services
2.3.5 Astellas Pharma Treatment for Genito-Urinary Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Treatment for Genito-Urinary Revenue, Gross Margin and Market Share (2018-2019)
2.5 Otsuka Pharmaceutical
2.5.1 Otsuka Pharmaceutical Details
2.5.2 Otsuka Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Otsuka Pharmaceutical SWOT Analysis
2.5.4 Otsuka Pharmaceutical Product and Services
2.5.5 Otsuka Pharmaceutical Treatment for Genito-Urinary Revenue, Gross Margin and Market Share (2018-2019)
2.6 Bayer
2.6.1 Bayer Details
2.6.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Bayer SWOT Analysis
2.6.4 Bayer Product and Services
2.6.5 Bayer Treatment for Genito-Urinary Revenue, Gross Margin and Market Share (2018-2019)
2.7 GSK
2.7.1 GSK Details
2.7.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 GSK SWOT Analysis
2.7.4 GSK Product and Services
2.7.5 GSK Treatment for Genito-Urinary Revenue, Gross Margin and Market Share (2018-2019)
2.8 Allergan
2.8.1 Allergan Details
2.8.2 Allergan Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Allergan SWOT Analysis
2.8.4 Allergan Product and Services
2.8.5 Allergan Treatment for Genito-Urinary Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Treatment for Genito-Urinary Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Treatment for Genito-Urinary Players Market Share
3.2.2 Top 10 Treatment for Genito-Urinary Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Treatment for Genito-Urinary Revenue and Market Share by Regions
4.2 North America Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
4.3 Europe Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
4.5 South America Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
5 North America Treatment for Genito-Urinary Revenue by Countries
5.1 North America Treatment for Genito-Urinary Revenue by Countries (2015-2020)
5.2 USA Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
5.3 Canada Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
5.4 Mexico Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
6 Europe Treatment for Genito-Urinary Revenue by Countries
6.1 Europe Treatment for Genito-Urinary Revenue by Countries (2015-2020)
6.2 Germany Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
6.3 UK Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
6.4 France Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
6.5 Russia Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
6.6 Italy Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Treatment for Genito-Urinary Revenue by Countries
7.1 Asia-Pacific Treatment for Genito-Urinary Revenue by Countries (2015-2020)
7.2 China Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
7.3 Japan Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
7.4 Korea Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
7.5 India Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
8 South America Treatment for Genito-Urinary Revenue by Countries
8.1 South America Treatment for Genito-Urinary Revenue by Countries (2015-2020)
8.2 Brazil Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
8.3 Argentina Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Treatment for Genito-Urinary by Countries
9.1 Middle East & Africa Treatment for Genito-Urinary Revenue by Countries (2015-2020)
9.2 Saudi Arabia Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
9.3 UAE Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
9.4 Egypt Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
9.5 South Africa Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Treatment for Genito-Urinary Revenue and Market Share by Type (2015-2020)
10.2 Global Treatment for Genito-Urinary Market Forecast by Type (2019-2024)
10.3 OTC Revenue Growth Rate (2015-2025)
10.4 Rx Drugs Revenue Growth Rate (2015-2025)
11 Global Treatment for Genito-Urinary Market Segment by Application
11.1 Global Treatment for Genito-Urinary Revenue Market Share by Application (2015-2020)
11.2 Treatment for Genito-Urinary Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2015-2020)
11.4 Drugs Store Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Treatment for Genito-Urinary Market Size Forecast (2021-2025)
12.1 Global Treatment for Genito-Urinary Market Size Forecast (2021-2025)
12.2 Global Treatment for Genito-Urinary Market Forecast by Regions (2021-2025)
12.3 North America Treatment for Genito-Urinary Revenue Market Forecast (2021-2025)
12.4 Europe Treatment for Genito-Urinary Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Treatment for Genito-Urinary Revenue Market Forecast (2021-2025)
12.6 South America Treatment for Genito-Urinary Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Treatment for Genito-Urinary Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Treatment for Genito-Urinary Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Treatment for Genito-Urinary by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Treatment for Genito-Urinary Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Treatment for Genito-Urinary Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Daiichi Sankyo Company Corporate Information, Location and Competitors
Table 6. Daiichi Sankyo Company Treatment for Genito-Urinary Major Business
Table 7. Daiichi Sankyo Company Treatment for Genito-Urinary Total Revenue (USD Million) (2017-2018)
Table 8. Daiichi Sankyo Company SWOT Analysis
Table 9. Daiichi Sankyo Company Treatment for Genito-Urinary Product and Solutions
Table 10. Daiichi Sankyo Company Treatment for Genito-Urinary Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Sanofi Corporate Information, Location and Competitors
Table 12. Sanofi Treatment for Genito-Urinary Major Business
Table 13. Sanofi Treatment for Genito-Urinary Total Revenue (USD Million) (2018-2019)
Table 14. Sanofi SWOT Analysis
Table 15. Sanofi Treatment for Genito-Urinary Product and Solutions
Table 16. Sanofi Treatment for Genito-Urinary Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Astellas Pharma Corporate Information, Location and Competitors
Table 18. Astellas Pharma Treatment for Genito-Urinary Major Business
Table 19. Astellas Pharma Treatment for Genito-Urinary Total Revenue (USD Million) (2017-2018)
Table 20. Astellas Pharma SWOT Analysis
Table 21. Astellas Pharma Treatment for Genito-Urinary Product and Solutions
Table 22. Astellas Pharma Treatment for Genito-Urinary Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Pfizer Corporate Information, Location and Competitors
Table 24. Pfizer Treatment for Genito-Urinary Major Business
Table 25. Pfizer Treatment for Genito-Urinary Total Revenue (USD Million) (2017-2018)
Table 26. Pfizer SWOT Analysis
Table 27. Pfizer Treatment for Genito-Urinary Product and Solutions
Table 28. Pfizer Treatment for Genito-Urinary Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Otsuka Pharmaceutical Corporate Information, Location and Competitors
Table 30. Otsuka Pharmaceutical Treatment for Genito-Urinary Major Business
Table 31. Otsuka Pharmaceutical Treatment for Genito-Urinary Total Revenue (USD Million) (2017-2018)
Table 32. Otsuka Pharmaceutical SWOT Analysis
Table 33. Otsuka Pharmaceutical Treatment for Genito-Urinary Product and Solutions
Table 34. Otsuka Pharmaceutical Treatment for Genito-Urinary Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Bayer Corporate Information, Location and Competitors
Table 36. Bayer Treatment for Genito-Urinary Major Business
Table 37. Bayer Treatment for Genito-Urinary Total Revenue (USD Million) (2017-2018)
Table 38. Bayer SWOT Analysis
Table 39. Bayer Treatment for Genito-Urinary Product and Solutions
Table 40. Bayer Treatment for Genito-Urinary Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. GSK Corporate Information, Location and Competitors
Table 42. GSK Treatment for Genito-Urinary Major Business
Table 43. GSK Treatment for Genito-Urinary Total Revenue (USD Million) (2017-2018)
Table 44. GSK SWOT Analysis
Table 45. GSK Treatment for Genito-Urinary Product and Solutions
Table 46. GSK Treatment for Genito-Urinary Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Allergan Corporate Information, Location and Competitors
Table 48. Allergan Treatment for Genito-Urinary Major Business
Table 49. Allergan Treatment for Genito-Urinary Total Revenue (USD Million) (2017-2018)
Table 50. Allergan SWOT Analysis
Table 51. Allergan Treatment for Genito-Urinary Product and Solutions
Table 52. Allergan Treatment for Genito-Urinary Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Treatment for Genito-Urinary Revenue (Million USD) by Players (2015-2020)
Table 54. Global Treatment for Genito-Urinary Revenue Share by Players (2015-2020)
Table 55. Global Treatment for Genito-Urinary Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Treatment for Genito-Urinary Revenue Market Share by Regions (2015-2020)
Table 57. North America Treatment for Genito-Urinary Revenue by Countries (2015-2020)
Table 58. North America Treatment for Genito-Urinary Revenue Market Share by Countries (2015-2020)
Table 59. Europe Treatment for Genito-Urinary Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Treatment for Genito-Urinary Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Treatment for Genito-Urinary Revenue by Countries (2015-2020)
Table 62. South America Treatment for Genito-Urinary Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Treatment for Genito-Urinary Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Treatment for Genito-Urinary Revenue Market Share by Countries (2015-2020)
Table 65. Global Treatment for Genito-Urinary Revenue (Million USD) by Type (2015-2020)
Table 66. Global Treatment for Genito-Urinary Revenue Share by Type (2015-2020)
Table 67. Global Treatment for Genito-Urinary Revenue Forecast by Type (2021-2025)
Table 68. Global Treatment for Genito-Urinary Revenue by Application (2015-2020)
Table 69. Global Treatment for Genito-Urinary Revenue Share by Application (2015-2020)
Table 70. Global Treatment for Genito-Urinary Revenue Forecast by Application (2021-2025)
Table 71. Global Treatment for Genito-Urinary Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Treatment for Genito-Urinary Picture
Figure 2. Global Treatment for Genito-Urinary Revenue Market Share by Type in 2019
Figure 3. OTC Picture
Figure 4. Rx Drugs Picture
Figure 5. Treatment for Genito-Urinary Revenue Market Share by Application in 2019
Figure 6. Hospital Picture
Figure 7. Drugs Store Picture
Figure 8. Other Picture
Figure 9. Global Treatment for Genito-Urinary Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Treatment for Genito-Urinary Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Treatment for Genito-Urinary Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Treatment for Genito-Urinary Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Treatment for Genito-Urinary Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Treatment for Genito-Urinary Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Treatment for Genito-Urinary Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Treatment for Genito-Urinary Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Treatment for Genito-Urinary Revenue Market Share in 2019
Figure 18. Global Top 10 Players Treatment for Genito-Urinary Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Treatment for Genito-Urinary Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Treatment for Genito-Urinary Revenue Market Share by Regions (2015-2020)
Figure 22. Global Treatment for Genito-Urinary Revenue Market Share by Regions in 2018
Figure 23. North America Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 24. Europe Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 26. South America Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 28. North America Treatment for Genito-Urinary Revenue Market Share by Countries (2015-2020)
Figure 29. North America Treatment for Genito-Urinary Revenue Market Share by Countries in 2019
Figure 30. USA Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 31. Canada Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 33. Europe Treatment for Genito-Urinary Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Treatment for Genito-Urinary Revenue Market Share by Countries in 2019
Figure 35. Germany Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 36. UK Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 37. France Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 38. Russia Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 39. Italy Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Treatment for Genito-Urinary Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Treatment for Genito-Urinary Revenue Market Share by Countries in 2019
Figure 42. China Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 43. Japan Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 44. Korea Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 45. India Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 47. South America Treatment for Genito-Urinary Revenue Market Share by Countries (2015-2020)
Figure 48. South America Treatment for Genito-Urinary Revenue Market Share by Countries in 2019
Figure 49. Brazil Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Treatment for Genito-Urinary Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Treatment for Genito-Urinary Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 54. UAE Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Treatment for Genito-Urinary Revenue and Growth Rate (2015-2020)
Figure 57. Global Treatment for Genito-Urinary Revenue Share by Type (2015-2020)
Figure 58. Global Treatment for Genito-Urinary Revenue Share by Type in 2019
Figure 59. Global Treatment for Genito-Urinary Market Share Forecast by Type (2021-2025)
Figure 60. Global OTC Revenue Growth Rate (2015-2020)
Figure 61. Global Rx Drugs Revenue Growth Rate (2015-2020)
Figure 62. Global Treatment for Genito-Urinary Revenue Share by Application (2015-2020)
Figure 63. Global Treatment for Genito-Urinary Revenue Share by Application in 2019
Figure 64. Global Treatment for Genito-Urinary Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospital Revenue Growth Rate (2015-2020)
Figure 66. Global Drugs Store Revenue Growth Rate (2015-2020)
Figure 67. Global Other Revenue Growth Rate (2015-2020)
Figure 68. Global Treatment for Genito-Urinary Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Treatment for Genito-Urinary Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Treatment for Genito-Urinary Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Treatment for Genito-Urinary Revenue Market Forecast (2021-2025)
Figure 72. Europe Treatment for Genito-Urinary Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Treatment for Genito-Urinary Revenue Market Forecast (2021-2025)
Figure 74. South America Treatment for Genito-Urinary Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Treatment for Genito-Urinary Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
泌尿生殖器-泌尿生殖器の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Genito-Urinary Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Genito-Urinary Drugs mar…- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 尿道スリングの世界市場（～2026年） Urinary incontinence slings are flexible surgical mesh systems that are placed surgically to restore the urethra to its normal position and efficiently minimize incontinence. A sling procedure uses strips of the body's tissue or synthetic mesh to create a hammock-like fixture that wraps around the b…
- 泌尿器治療薬の世界市場（～2026年） Market Analysis and Insights: Global Urinary Drugs Market The global Urinary Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Urinary Drugs Scope and Market Size Urinary Drugs market is segmented by Type, and by A…
- 腹圧性尿失禁用ペッサリーの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Pessary for Stress Urinary Incontinence market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value c…